For Further Information, Contact:
John Wood
President & CEO
(978) 977-3000

Analogic Corporation Receives New Order for Its
EXplosive Assessment Computed Tomography Systems

PEABODY, MA (February 9, 2005) – John Wood, President and CEO of Analogic Corporation (NASDAQ: ALOG), announced today that the Company has received a new order for its EXplosive Assessment Computed Tomography (EXACT™) Systems from L-3 Communications’ (NYSE: LLL) subsidiary, L-3 Communications Security and Detection Systems, Inc. The order has a value of approximately $25,000,000. Shipments will begin in June 2005 and continue into February 2006. Analogic is currently shipping units to fulfill an earlier order of similar scope from L-3. Shipments for that order, originally scheduled to be completed in December 2005, will be accelerated for completion in June 2005.

“This is a significant order from L-3 Communications and we are pleased to have received it,” John Wood said. “These units will include our new full-field-of-view computer with improved reconstruction capability to better image a variety of bag sizes. This major enhancement is part of our continuing commitment to improve explosives detection technology.” Analogic’s EXACT systems are built in a new 50,000-square-foot security manufacturing facility at the Company’s Peabody headquarters.

The EXACT is the “heart” of L-3’s eXaminer 3DX® 6000, a certified Explosives Detection System (EDS) that has been purchased by the U.S. Transportation Security Administration (TSA) and installed at major airports across the U.S. The L-3 systems are also installed at a number of leading international airports, including Israel’s Ben Gurion Airport, Singapore’s Changi Airport, and Italy’s Fiumicino and Ciampino airports.

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multiprocessing.

This press release reflects the Company’s or management’s intentions, hopes, beliefs, expectations, or predictions. These are considered “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements (statements that are not historical facts) in this press release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements, including statements about product development, market and industry trends, strategic initiatives, regulatory approvals, sales, profits, expenses, price trends, research and development trends, and capital expenditures, involve risks and uncertainties, and that actual events and results may differ significantly from those anticipated in such statements. Actual results may differ materially from those anticipated in such forward-looking statements as a result of various factors, including those discussed in the Company’s periodic reports filed with the SEC.

TERMS OF USE
© 2003 Analogic Corporation. All rights reserved

Back to Home Page